Liposomal Efficacy Goes Beyond Imagination: Proven by Data and Result-(Part 1)

The global market for liposomal supplements is undergoing rapid expansion. According to data from the Jiuqian Zhongtai platform, the U.S. market for liposomal dietary supplements recorded a compound annual growth rate of 52% between 2021 and 2024. Behind this remarkable growth lies a growing consumer expectation: nutritional supplements must be truly effective.

However, moving beyond marketing claims, how can brands and consumers scientifically and objectively verify a product’s absorption efficiency? The answer lies in systematic and rigorous scientific evaluation of bioavailability.

Bioavailability, defined as the efficiency and extent to which an active ingredient is absorbed and utilized in the body, is the decisive indicator linking formulation design to real physiological outcomes. Accurate assessment depends on a mature, multi-level scientific framework that generally falls into two categories. The first is in vitro testing, which focuses on early-stage screening and prediction and is widely used for formulation optimization due to its cost-effectiveness. The second is in vivo testing, regarded as the ultimate “gold standard,” providing the most reliable evidence through experiments conducted in living organisms.

To address the diverse physicochemical properties and absorption challenges of different ingredients, Effepharm designs customized evaluation pathways from in vitro to in vivo testing. This approach begins with simulated digestion and cell-based models to efficiently screen and predict absorption potential, followed by animal studies and clinical trials designed on the basis of in vitro results. By combining the efficiency of in vitro methods with the authority of in vivo validation, Effepharm ensures that every product optimized with LipoAvail® liposomal technology is supported by the most relevant and robust scientific data. Our goal is to translate rigorous methodology into credible product performance, delivering high-efficiency solutions that stand up to multidimensional scientific validation.

01

In Vitro Methods: The Scientific Frontier of Efficient Prediction and Formulation Optimization

In vitro methods do not involve experiments conducted directly in living organisms. Instead, they precisely simulate human digestive and absorption environments under laboratory conditions, enabling early prediction and efficient screening of active ingredient absorption. With advantages such as lower cost, shorter timelines, and higher throughput, these methods are particularly well suited for formulation optimization and absorption potential assessment in early-stage product development, making them indispensable tools in modern liposomal delivery research.

In Vitro Simulated Digestion Studies

Simulated digestion studies replicate the human gastrointestinal process under controlled conditions to evaluate how active ingredients are released at different stages, providing key data for predicting bioavailability.

Release Rate Studies

Release rate testing is a core method for evaluating how formulation technologies influence the release behavior of active ingredients. By precisely simulating digestive conditions, researchers dynamically monitor the rate and extent to which active compounds are released from different delivery system, such as liposomes or microcapsules, thus offering valuable insight into their expected in vivo absorption efficiency.

These studies strictly follow the chronological sequence of human digestion. Samples are sequentially exposed to simulated oral, gastric, and intestinal media. During the critical gastric and intestinal phases, samples are collected at multiple time points to quantify released active ingredients and generate complete release profiles, revealing formulation performance under different physiological conditions.

Application example:
Release-rate data for liposomal curcumin formulated with LipoAvail® technology clearly demonstrate the sustained-release advantages of liposomal technology. During a two-hour simulated gastric digestion phase, the release rate gradually increased to 71.5%, indicating that a portion of curcumin remained encapsulated within the liposomal structure. This reflects how the phospholipid bilayer acts as a physical barrier, protecting the active compound from degradation in harsh gastric acidic environments, offering a clear scientific explanation to the common question: how do liposomes work?

When conditions shifted to simulated intestinal digestion, curcumin release gradually increased to 100% within two hours, confirming the strong sustained-release performance of the liposomal delivery system.

Figure 1. Release rate comparison between regular curcumin and LipoAvail® liposomal curcumin

To date, LipoAvail® liposomal products that have completed release-rate studies include liposomal vitamins (such as liposomal vitamin C), liposomal ferric pyrophosphate, liposomal NAD+, and liposomal glutathione. Across these products, data consistently demonstrate pronounced sustained-release characteristics, validating the reliability and consistency of liposomal benefits in controlled release and absorption enhancement.

This distinctive “gastric protection + intestinal sustained release” pattern aligns perfectly with the ideal design principles of oral delivery systems. It preserves ingredient stability in acidic gastric conditions while enabling gradual and complete release in the intestine, ensuring higher bioavailability during the optimal absorption window and laying a strong foundation for improved oral bioavailability.

2. Cell-Based Models

Cell-based models are central in vitro tools for investigating intestinal absorption mechanisms and predicting absorption efficiency. Among them, the Caco-2 cell model is widely recognized as the in vitro “gold standard” for evaluating intestinal absorption due to its ability to closely mimic the structure and function of human intestinal epithelium.

Model Principles and Operation

In this model, human colon carcinoma cells (Caco-2) spontaneously differentiate under specific culture conditions into a monolayer with microvilli and tight junctions, closely resembling the human intestinal barrier. During experiments,  samples are applied to the apical side (simulating the intestinal lumen), while the amount transported to the basolateral side (simulating systemic circulation) is measured over time to assess transmembrane transport capability.

Key Evaluation Metrics and Applications

Primary Metric 1: Absorption Rate

Absorption rate directly quantifies how efficiently an active ingredient is taken up or utilized by cells. In addition to measuring transport volume, downstream biomarkers triggered by ingredient uptake, such as ferritin or metabolic enzymes, can be analyzed to indirectly calculate absorption efficiency.

Application example:
When evaluating LipoAvail® liposomal ferric pyrophosphate, cell-model data showed intracellular ferritin levels reaching 105.62 ng/mg total protein, 4.31 times higher than the regular ferric pyrophosphate group (24.49 ng/mg total protein). This substantial difference demonstrates that liposomal technology significantly enhances cellular uptake and storage of iron, thereby improving its absorption rate.

Figure 2. In vitro bioavailability comparison between regular ferric pyrophosphate and LipoAvail® liposomal ferric pyrophosphate

Primary Metric 2: Apparent Permeability Coefficient (Papp)

The apparent permeability coefficient (Papp) is a key kinetic parameter used to quantitatively assess an active ingredient’s ability to cross biological barriers such as the intestinal epithelium. Higher Papp values indicate faster membrane permeation. For end-Product consumers, this translates into better in vivo absorption efficiency, addressing the frequently asked question: do liposomes actually work?

Application example:
As one of the most closely watched supplement ingredients today, liposomal NAD+ is often evaluated based on its absorption efficiency. Due to its relatively large molecular size and complex structure, NAD+ is inherently difficult to absorb. To scientifically verify the effect of LipoAvail® technology, researchers conducted Caco-2 cell studies comparing regular NAD+ and liposomal NAD+.

Results showed that LipoAvail® liposomal NAD+ achieved a significantly higher Papp value than regular NAD+, confirming enhanced transmembrane transport at the cellular level.

Figure 3. Papp comparison between regular NAD+ and LipoAvail® liposomal NAD+

As shown in Figure 3, differentiated Caco-2 monolayer transport studies demonstrated a Papp value of 8.17 × 10⁻⁶ cm/s for LipoAvail® liposomal NAD+, compared with 3.55 × 10⁻⁶ cm/s for regular NAD+, a 2.30-fold increase. This improvement is largely attributed to the liposomal bilayer structure, which closely resembles human cell membranes and provides an efficient absorption pathway for otherwise poorly permeable molecules.

To further validate absorption kinetics, researchers monitored NAD+ concentration changes over time in the Transwell basolateral chamber, simulating systemic circulation.

Figure 4. Time-dependent NAD+ concentration in the Transwell basolateral chamber: regular NAD+ vs. LipoAvail® liposomal NAD+

The NAD+ concentration–time curves provide dynamic and intuitive evidence supporting these findings. Throughout the monitoring period, NAD+ accumulation on the basolateral side remained consistently higher in the LipoAvail® liposomal NAD+ group. This not only confirms higher total absorption, but also highlights a critical advantage: stable and sustained improvement in absorption rate. For compounds like NAD+ that lack efficient natural transport mechanisms, liposomal delivery effectively overcomes inherent absorption barriers and represents a fundamental breakthrough in bioavailability.

At present, LipoAvail® liposomal technology has been applied and validated in cell absorption studies for multiple ingredients, including curcumin, vitamin C, NAD+, and glutathione. The core value of this model lies in early-stage development, it enables rapid, low-cost screening and formulation optimization, generates key absorption data at the R&D stage, and significantly reduces downstream uncertainty and development costs by providing reliable early scientific evidence.

Looking Ahead: From In Vitro Insight to In Vivo Proof

With their efficiency and controllability, in vitro methods offer powerful tools for optimizing formulations and predicting absorption potential. Whether through simulated digestion release profiles or cell-model permeability data, they clearly illustrate the pathways for enhancing bioavailability. However, laboratory simulations cannot fully replicate the complex dynamics of living systems. To build the most authoritative and convincing evidence base, validation in environments closer to real physiology, in vivo studies, is essential.

So how can formulations that perform well in vitro be tested in real biological systems? In Part 2, we will explore in vivo methods, centered on animal studies and clinical trials, which reveal the complete picture of absorption, distribution, and metabolism, and provide the undisputed “gold standard” proof behind the real-world effectiveness of liposomal supplements and their scientifically validated liposomal benefits.